Related Experiment Video
Updated: May 10, 2026

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
Update on the protective molecular pathways improving pancreatic beta-cell dysfunction
Alessandra Puddu1, Roberta Sanguineti, François Mach
1Department of Internal Medicine, University of Genoa, Viale Benedetto XV 6, 16132 Genova, Italy.
Abstract:
The primary function of pancreatic beta-cells is to produce and release insulin in response to increment in extracellular glucose concentrations, thus maintaining glucose homeostasis. Deficient beta-cell function can have profound metabolic consequences, leading to the development of hyperglycemia and, ultimately, diabetes mellitus. Therefore, strategies targeting the maintenance of the normal function and protecting pancreatic beta-cells from injury or death might be crucial in the treatment of diabetes. This narrative review will update evidence from the recently identified molecular regulators preserving beta-cell mass and function recovery in order to suggest potential therapeutic targets against diabetes. This review will also highlight the relevance for novel molecular pathways potentially improving beta-cell dysfunction.
Insights
Maintaining pancreatic beta-cell function is key to preventing diabetes. This review explores molecular regulators that preserve beta-cell mass and function, offering potential therapeutic targets for diabetes treatment.
Area of Science:
- Endocrinology
- Metabolic diseases
- Cell biology
Background:
- Pancreatic beta-cells are crucial for insulin production and glucose homeostasis.
- Impaired beta-cell function leads to hyperglycemia and diabetes mellitus.
- Protecting beta-cells from damage is vital for diabetes management.
Purpose of the Study:
- To review recent molecular regulators of beta-cell mass and function.
- To identify potential therapeutic targets for diabetes treatment.
- To highlight novel pathways for improving beta-cell dysfunction.
Main Methods:
- Narrative review of existing scientific literature.
- Analysis of recently identified molecular regulators.
- Synthesis of evidence on beta-cell preservation and recovery.
Main Results:
- Several molecular regulators have been identified that preserve beta-cell mass.
- Evidence suggests these regulators can promote beta-cell function recovery.
- Novel molecular pathways show promise for enhancing beta-cell function.
Conclusions:
- Targeting molecular regulators offers a promising therapeutic strategy for diabetes.
- Preserving beta-cell function and mass is critical for diabetes treatment.
- Further research into novel pathways could lead to improved diabetes therapies.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Diabetic Neuropathy
Chronic Pancreatitis II: Pathophysiology

